CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | Nash Duane Executive Chairman | Purchase | +1,000 | $9.80 | $10K | 15,032 |
| 2021-06-10 | Nash Duane Executive Chairman | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2021-06-10 | Ossipow Vincent Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2021-06-10 | HOWSON TAMAR D Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2021-06-10 | PHILLIPS BARCLAY A Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2021-06-10 | Neermann Joerg Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2021-06-10 | van den Bossche Jan Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2021-05-12 | Nash Duane Executive Chairman | Purchase | +4,000 | $12.75 | $51K | 14,032 |
| 2021-04-15 | Nash Duane Executive Chairman | Grant or award · Stock Option | +90,000 | 90,000 | ||
| 2021-03-02 | Muehler Andreas Chief Medical Officer | Purchase | +10,006 | $15.54 | $155K | 294,486 |
| 2021-03-02 | Whaley Glenn PFO and PAO | Purchase | +1,000 | $16.48 | $16K | 2,000 |
| 2021-03-01 | Whaley Glenn PFO and PAO | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-03-01 | Groeppel Manfred Chief Operating Officer | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2021-03-01 | Vitt Daniel Chief Executive Officer | Grant or award · Stock Option | +115,000 | 115,000 | ||
| 2020-10-22 | Nash Duane Executive Chairman | Grant or award · Stock Option | +120,000 | 120,000 | ||
| 2020-08-10 | Whaley Glenn PFO and PAO | Purchase | +1,000 | $18.96 | $19K | 1,000 |
| 2020-07-21 | Groeppel Manfred Chief Operating Officer | Sale | −650 | $15.62 | $10K | 278,830 |
| 2020-07-21 | Vitt Daniel Chief Executive Officer | Sale | −1,300 | $15.62 | $20K | 362,877 |
| 2020-07-20 | Groeppel Manfred Chief Operating Officer | Sale | −5,000 | $14.44 | $72K | 279,480 |
| 2020-07-20 | Vitt Daniel Chief Executive Officer | Sale | −5,000 | $14.44 | $72K | 364,177 |
Page 10 of 16 · 311 trades